Jin Medical International Ltd. (NASDAQ: ZJYL)

Jin Medical International Ltd., also known as ZJYL, is a company that operates in the medical device industry, specifically in the design and manufacture of wheelchairs and living aids products. The company was established in 2006 and has its headquarters in Changzhou, China.

ZJYL's primary business activities involve the design, production, and sale of wheelchairs and living aids products. These products include oxygen concentrators and bathing machines, which are designed to assist people with disabilities or chronic illnesses. The company operates in three segments: wheelchairs, living aids products, and other products. The wheelchair segment is the largest and most profitable, accounting for approximately 96.5% of the company's revenue. The living aids products segment accounts for around 3.5% of the revenue, while the other products segment makes up the remaining 0.1%.

The company generates revenue through the sale of its products to dealers in Japan and China, as well as to selected customers in other regions. The majority of ZJYL's sales are attributed to its largest dealer, Nissin Medical Industries Co., Ltd., a leading medical device distributor in Japan. The company's products are designed to be lightweight, ergonomic, and customizable, and the company places a strong emphasis on quality control and customer satisfaction.

ZJYL's competitive advantages include its strong focus on quality control, its ability to customize products to meet customer needs, and its established relationships with dealers and distributors in Japan and China. The company's management team has extensive experience in R&D, manufacturing, and commercialization of wheelchairs and living aids products.

The company's wheelchairs are designed to be manual, with a wide range of products at various price points. ZJYL also offers electric wheelchairs, which accounted for approximately 0.2% of its revenue in the fiscal year ended September 30, 2023.

ZJYL's R&D department is led by its CEO, Dr. Erqi Wang, with a team of 55 employees, most of whom have advanced degrees in engineering and related fields. The company's R&D department is responsible for delivering new wheelchair designs each year and has developed several new living aids products since 2019.

In terms of raw materials and suppliers, ZJYL sources its raw materials and components from PRC domestic suppliers. The company selects suppliers based on criteria such as quality, production site, production process, delivery cycle, and price. ZJYL's main raw materials include steel, aluminum, titanium, various alloys, plastics, electronic components, sponges, leather, and PU foam.

The company's production facilities are located in Changzhou and Taizhou, Jiangsu Province, China. ZJYL operates two manufacturing plants, with a total area of approximately 228,257 square feet. The company's equipment was valued at approximately $0.3 million as of September 30, 2023, net of depreciation costs.

ZJYL's financial performance has been strong in recent years, with revenue increasing by 3.3% to $19,821,457 in the fiscal year ended September 30, 2023, compared to the same period in the previous year. The company's net income also increased by 6.3% to $2,878,230 in the same period.